Piper Sandler Maintains Overweight on Braze, Lowers Price Target to $27

Benzinga Newsdesk www.benzinga.com Negative 80.4%

Neg 80.4% Neu 0% Pos 0%

Piper Sandler analyst Billy Fitzsimmons maintains Braze (NASDAQ:BRZE) with a Overweight and lowers the price target from $30 to $27.